HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Nakaraang pagsara
₹714.30
Sakop ng araw
₹715.15 - ₹749.10
Sakop ng taon
₹603.80 - ₹1,997.40
Market cap
37.51B INR
Average na Volume
197.26K
P/E ratio
37.63
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Investor's Business Daily
1 oras ang nakalipas
Dow Jones AI Giant Nvidia Stock Breaks Out To New Highs
2.22%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.37B | 9.39% |
Gastos sa pagpapatakbo | 803.51M | 65.13% |
Net na kita | 222.95M | -33.50% |
Net profit margin | 9.39 | -39.18% |
Kita sa bawat share | 4.40 | — |
EBITDA | 277.48M | -6.06% |
Aktuwal na % ng binabayarang buwis | -0.18% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.80B | 4,868.40% |
Kabuuang asset | 16.88B | 8.63% |
Kabuuang sagutin | 4.21B | 9.42% |
Kabuuang equity | 12.67B | — |
Natitirang share | 50.67M | — |
Presyo para makapag-book | 2.86 | — |
Return on assets | — | — |
Return on capital | 3.38% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 222.95M | -33.50% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Itinatag
1992
Website
Mga Empleyado
871
